Source:http://linkedlifedata.com/resource/pubmed/id/18216178
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-19
|
pubmed:abstractText |
In contrast to most antimicrobial classes, there is a doubt about the impact of protein binding (PB) on the antimicrobial activity of fluoroquinolones. We set out to evaluate the suitability of previously used models for investigating the influence of PB on bacterial killing by fluoroquinolones.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1460-2091
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
561-7
|
pubmed:meshHeading |
pubmed-meshheading:18216178-Anti-Infective Agents,
pubmed-meshheading:18216178-Blood Proteins,
pubmed-meshheading:18216178-Fluoroquinolones,
pubmed-meshheading:18216178-Humans,
pubmed-meshheading:18216178-Microbial Sensitivity Tests,
pubmed-meshheading:18216178-Protein Binding,
pubmed-meshheading:18216178-Pseudomonas aeruginosa,
pubmed-meshheading:18216178-Staphylococcus aureus
|
pubmed:year |
2008
|
pubmed:articleTitle |
Plasma protein binding of fluoroquinolones affects antimicrobial activity.
|
pubmed:affiliation |
Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Austria. markus.zeitlinger@meduniwien.ac.at
|
pubmed:publicationType |
Journal Article,
Comparative Study
|